Working... Menu

Long Non Coding RNA in Complications of Systemic Lupus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03185767
Recruitment Status : Unknown
Verified June 2017 by mai ahmec, Cairo University.
Recruitment status was:  Recruiting
First Posted : June 14, 2017
Last Update Posted : June 14, 2017
Information provided by (Responsible Party):
mai ahmec, Cairo University

Brief Summary:
the precise role of RNA in setting of this complication in systemic lupus erythematosus (SLE) is largely unknown

Condition or disease Intervention/treatment Phase
Complication in Systemic Lupus Erythematosus Other: blood sampling Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Diagnostic
Official Title: Long Non Coding RNA IN Systemic Lupus
Actual Study Start Date : June 1, 2016
Estimated Primary Completion Date : June 30, 2017
Estimated Study Completion Date : July 1, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Lupus

Arm Intervention/treatment
SLE group Other: blood sampling
blood sampling

control group Other: blood sampling
blood sampling

Primary Outcome Measures :
  1. non coding RNA expression by real time PCR [ Time Frame: 1 year ]
    non coding RNA expression by real time PCR to evaluate thier role in lupus

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • with systemic lupus

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03185767

Layout table for location information
Cairo University Recruiting
Cairo, Egypt, 202
Contact: mai ahmed, master    01066625682   
Sponsors and Collaborators
Cairo University

Layout table for additonal information
Responsible Party: mai ahmec, teaching assistant, Cairo University Identifier: NCT03185767     History of Changes
Other Study ID Numbers: 12345SLE
First Posted: June 14, 2017    Key Record Dates
Last Update Posted: June 14, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Lupus Erythematosus, Systemic
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases